seattle genetics inc news
Your Search Returned 17 tagged news reports
Seattle Genetics Reports First Quarter 2013 Financial Results
Bothell :: WA :: USA | 1 month ago
Credibility
Product Development Pipeline and Advances with Industry-Leading Antibody-Drug Conjugate (ADC) Technology- -Conference call today at 4:30 p.m...Siegall, Ph.D., President and Chief Executive Officer at Seattle Genetics...Seattle Genetics is also
Tags:
Seattle Genetics and Collaborators Highlight Multiple Antibody-Drug Conjugate (ADC) Programs and Technology Advances at AACR
Bothell :: WA :: USA | 2 months ago
Credibility
Three data presentations highlight the rapid progress being made in ADC technology and testing. This includes preclinical data evaluating ADCs using a potent and newly developed cytotoxic agent, pyrrolobenzodiazepine (PBD) dimer, against two targets,
Tags:
'Living with Cancer' class begins Thursday
Pasco :: WA :: USA | almost 2 years ago
Credibility
Colon cancer awareness Colon cancer awareness In Louie Smith's May 2 letter to the Herald on the colon cancer awareness campaign, he comments on the distasteful remark, "What's up your butt?" and how we have become more tolerant of "disrespectful and
Tags:
FDA approves Seattle Genetics drug for 2 cancers
Washington :: DC :: USA | almost 2 years ago
Credibility
Federal regulators have approved an innovative cancer drug from Seattle Genetics Inc. to treat two rare forms of cancer that attack the lymph nodes. The Food and Drug Administration says it approved Adcetris to treat Hodgkin's
Tags:
A.M. Vitals: FDA Panel Endorses Seattle Genetics Lymphoma Drug
Coronado :: CA :: USA | almost 2 years ago
Credibility
An FDA advisory panel unanimously recommended the accelerated approval of brentuximab vodotin, an experimental lymphoma drug that Seattle Genetics wants to market under the brand name Adcetris, the WSJ reports . Accelerated approval requires further
Tags:
FDA is reviewing Seattle Genetics drug
Olympia :: WA :: USA | 2 years ago
Credibility
The company said the FDA will make separate decisions on the two applications by Aug. 30. Seattle Genetics filed for marketing approval of the drug, called brentuximab, as a treatment for patients whose cancer did not respond to other drugs or has
Tags:
Compugen, Seattle Genetics to collaborate
New York City :: NY :: USA | over 2 years ago
Credibility
Seattle Genetics, Inc., USA covering a Compugen-discovered oncology target. The agreement provides Seattle Genetics with an initial evaluation period and an option for an exclusive worldwide milestone and royalty bearing license for development and
Tags:
Seattle Genetics cancer drug meets study goal
New York :: NY :: USA | over 2 years ago
Credibility
The Bothell, Wash., company is testing brentuximab, or SGN-35, as a potential treatment for Hodgkin's lymphoma that has recurred or not responded to stem cell treatment. The study of 102 patients showed 75 percent had an objective response to the
Tags:
Genentech pays $12M to expand Seattle Genetics pact
South San Francisco :: CA :: USA | almost 3 years ago
Credibility
Find Executives Genentech Inc. will pay $12 million cash upfront to Seattle Genetics Inc. and up to $900 million overall under an expanded 8-year-old deal that makes antibodies more powerful and targeted against cancer...Genentech is responsible for
Tags:
Roche Terminates Seattle Genetics Collaboration
London :: United Kingdom | over 3 years ago
Credibility
Seattle Genetics Inc. said Friday that Genentech, a division of Roche Holdings , has terminated the companies' collaboration agreement for dacetuzumab. The decision is a result of Genentech's ongoing portfolio review process, Seattle Genetics said.
Tags:
